Motilal Oswal: Alembic Pharma Q2 Review - Non-U.S., API Outperforms; U.S. Momentum Sustains
Medicinal tablets are arranged for a photograph in Mumbai. (Photographer: Dhiraj Singh/Bloomberg)

Motilal Oswal: Alembic Pharma Q2 Review - Non-U.S., API Outperforms; U.S. Momentum Sustains

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer Bl...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.